Clinical Pharmacology of Vecuronium and Atracurium

Overview

Journal Anesthesiology

Specialty Anesthesiology

Date 1984 Oct 1

PMID 6148907

Citations 20

Authors

R D Miller

S M Rupp

D M Fisher

R Cronnelly

M R Fahey

Y J Sohn

Affiliations

Soon will be listed here.

Abstract

Vecuronium and atracurium provide addition flexibility to the clinician using neuromuscular blocking drugs. The shorter duration of action, lack of significant cardiovascular effects, and the lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available nondepolarizing neuromuscular blocking drugs.

Citing Articles

Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review.

Radkowski P, Szewczyk M, Leczycka A, Kowalczyk K, Keska M, Stompor T Med Sci Monit. 2025; 31:e945822.

PMID: 39741402 PMC: 11702445. DOI: 10.12659/MSM.945822.

Anesthetic management of a child with Aicardi syndrome undergoing laparoscopic Nissen's fundoplication: a case report.

Terakawa Y, Miwa T, Mizuno Y, Ichinohe T, Kaneko Y, Ka K J Anesth. 2010; 25(1):123-6.

PMID: 21153034 DOI: 10.1007/s00540-010-1059-2.

Difference in the effect of pancuronium and vecuronium on baroreflex control of heart rate in humans.

Tsuchida H, Seki S, Nakae Y, Namiki A J Anesth. 1991; 5(3):255-9.

PMID: 15278627 DOI: 10.1007/s0054010050255.

Quantitative determination of atracurium in human plasma using high-performance liquid chromatography.

Okutani R, Kono K, DeBros F, Philbin D J Anesth. 1988; 2(2):213-8.

PMID: 15236083 DOI: 10.1007/s0054080020213.

Continuous infusion of vecuronium in children.

Obara H, Hoshina H, Tanaka O, Chuma R, Kaetsu H, Maekawa N J Anesth. 1988; 2(1):8-11.

PMID: 15235826 DOI: 10.1007/s0054080020008.